Monday 11 April 2016

• 17:00 - Innovation in Immunotherapy
  Professor Paresh Vyas (University of Oxford, Weatherall Institute of Molecular Medicine), Prof Vincenzo Cerundolo (MRC Human Immunology Unit, WIMM, University of Oxford), Dr Bent Jakobsen (Chief Scientific Officer, Immunocore), Martin Pule (Cancer Institute, UCL), Dr Robert Wilkinson (Director of Oncology Research, MedImmune Ltd), Prof Sarah Gilbert (Professor of Vaccinology at Oxford University, Founder of Vaccitech), Dr Eliot Forster (CEO of Immunocore Ltd), Dr Lucinda Crabtree (Senior Investment Analyst, Woodford Investment Management LLP), Prof Mark Middleton (Lead Cancer Clinician for the Oxford University Hospitals NHS Foundation Trust and deputy director of the Cancer Research UK Oxford Centre)

Monday 4 December 2017

• 09:00 - Innovation Forum Leaders Conference
  Professor Sir John Bell (Regius Professor of Medicine, University of Oxford), Dr Eliot Forster (CEO of Immunocore Ltd), Gordon Sanghera (CEO Oxford Nanopore Technologies), Jonathan Milner (Investor, Philanthropist, Serial Entrepreneur), Rt Hon. Lord David Willetts (Former Minister of State for Universities and Science), Dr Bruno Holthof (CEO Oxford University Hospitals NHS Trust), Lord Paul Drayson (Chairman and CEO Drayson Technologies), Richard Mason (Head of Johnson & Johnson Innovation, London), Ian Tomlinson (Chairman, Apollo Therapeutics Fund), Dr James Sabry (Senior Vice President, Genentech Partnering), Natasha Loder ( The Economist)